Publications by authors named "Veli Sunar"

Claim this Profile
R
Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.
Seda Kahraman, Enes Erul, Ozge Gumusay, Deniz Can Guven, Sercan Aksoy, Veli Sunar

Clin Breast Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study.
Seda Kahraman, Mutlu Hizal, Burcin Cakan Demirel, Deniz Can Guven, Ozge Gumusay, Veli Sunar

BMC Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological features of non-carcinoid malignant epithelial appendix tumors and risk factors for recurrence, single-center experience.
Ozturk Ates, Bulent Aksel, Ibrahim Karadag, Serdar Karakaya, Veli Sunar

Indian J Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study.
Elif Şenocak Taşçı, Yasin Kutlu, Ömer Fatih Ölmez, Arda Ulaş Mutlu, Yasemin Gündoğdu, Veli Sunar

Expert Opin Pharmacother· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer.
Cengiz Karacin, Veli Sunar, Zuhat Urakci, Ali Yilmaz, Murat Ayhan

Future Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.
Ahmet Bilici, Sinan Koca, Mustafa Karaagac, Sabin Goktas Aydin, Emrah Eraslan, Veli Sunar

J Cancer Res Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
Seda Kahraman, Enes Erul, Mustafa Seyyar, Ozge Gumusay, Ertugrul Bayram, Veli Sunar

Future Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of weekly methotrexate regimen versus methotrexate folinic acid 8-day regimen for treatment of low-risk gestational trophoblastic neoplasia.
Vakkas Korkmaz, Veli Sunar, Serra Akar, Cihat Murat Alinca, Zafer Arik

Asia Pac J Clin Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of germline BRCA1/2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer.
Veli Sunar, Vakkas Korkmaz, Vehap Topcu, Büşranur Cavdarli, Zafer Arik

Asia Pac J Clin Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Pazopanib in patients with metastatic uterine sarcoma: A multi-institutional study.
Veli Sunar, Vakkas Korkmaz, Serkan Akin, Deniz Can Guven, Zafer Arik

J BUON· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of the 2017 World Health Organization Classification System for gastric neuroendocrine tumors: A single-center experience.
Yusuf Karakaş, Şahin Laçin, Olcay Kurtulan, Ece Esin, Veli Sunar

Turk J Gastroenterol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between androgen receptor status and prognosis in triple negative breast cancer.
Veli Sunar, Hayriye T Dogan, Furkan Sarici, Ozturk Ates, Serkan Akin

J BUON· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The short-term safety of adjuvant paclitaxel plus trastuzumab - A single centre experience.
Ozturk Ates, Veli Sunar, Alma Aslan, Fatih Karatas, Suleyman Sahin

J BUON· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prevalence of Systemic Rheumatic Diseases Among Breast Cancer Patients and Its Relationship With Survival.
Veli Sunar, Öztürk Ateş, Alma Korcali Aslan, Yusuf Karakaş, Mustafa Kadri Altundağ

Arch Rheumatol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experience.
Furkan Sarici, Taner Babacan, Hakan Buyukhatipoglu, Ozan Balakan, Ali R Sever, Veli Sunar

J BUON· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When should we give aromatase inhibitors for insomnia; early in the day or after dinner?
Ozturk Ates, Veli Sunar, Ali R Sever, Kadri Altundag

J BUON· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab.
Ozturk Ates, Veli Sunar, Taner Babacan, Serkan Akin, Neyran Kertmen

J BUON· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis